Wire Stories
-
18.0KConstl, a Space World Company, Selects Ciena Optical Technology to Offer High-Capacity Digital Connectivity in India
Ciena technology being deployed across Constl’s multiple metros and pan-India NLD networks NEW DELHI, India–(BUSINESS WIRE)–Constl, a subsidiary of Space World Group,...
-
11.4KImmuneOncia Announces Biomarker Results from Phase 1 Clinical Trial of CD47 Antibody at ASCO
SEOUL, South Korea–(BUSINESS WIRE)–#2024ASCOAnnualMeeting—ImmuneOncia (CEO Heung Tae Kim) announced the results of its solid tumour Phase 1a clinical trial of IMC-002, an...
-
11.0KOutsource Accelerator Calls for Outsourcing Impact Review 2024 Entries
MANILA, Philippines–(BUSINESS WIRE)–#CSR—Outsource Accelerator, the premier source of independent information, advisory, and advocacy for the outsourcing industry, is excited to announce the...
-
13.7KBionova Scientific, U.S. biologics CDMO of the Asahi Kasei Group, to establish a facility in Texas and launch plasmid DNA business
TOKYO & NEW YORK & DÜSSELDORF, Germany–(BUSINESS WIRE)–Asahi Kasei Medical’s U.S. subsidiary Bionova Scientific, a full-service biologics CDMO, has decided to launch...
-
15.7KAKM Achieves Successful Proof of Concept for eFuse in High Voltage 800 V Automotive Applications
Door opener for compact, fast and reliable protection of e.g., on-board chargers or DC/DC converters for electric vehicles TOKYO & NEW YORK...
-
11.9KEnergy Vault Executes EPC and O&M Contract with ACEN Australia for 200 MW/400 MWh of Battery Energy Storage Deployments
ACEN Australia and Energy Vault to begin deployment of two battery energy storage systems (BESS), with a total capacity of 200 MW/400...
-
11.8KDebiopharm and Genome & Company Reach Agreement for Potential First-In Class Oncology Antibody Drug Conjugate Family
Debiopharm granted exclusive global rights to use Genome & Company’s antibodies to develop potential first-in-class ADCs integrating Debiopharm’s Multilink™ technology. LAUSANNE, Switzerland...
-
14.0KInocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching
SAN DIEGO–(BUSINESS WIRE)–#WGS–Inocras, a leading AI-driven whole genome testing company, and Massive Bio, a cutting-edge AI-driven clinical trial matching platform provider, have...
-
13.3KInternational Energy Forum Report Details EV Copper Hurdles
Generation Mining Hosting Fireside Chat with Report Co-Author TORONTO–(BUSINESS WIRE)–$genm #copper–Generation Mining Limited (TSX:GENM, OTCQB: GENMF) welcomes the recent report by the...
-
21.0KTakeda’s TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to Placebo
– Phase 2b Trial Demonstrated Statistically Significant and Clinically Meaningful Improvements Across Primary and all Secondary Endpoints up to 8 Weeks –...
To Top